Researchers find TEG test can identify undetected blood clots in COVID-19 ICU patients

June 05, 2020

Researchers at Baylor College of Medicine are recommending that all COVID-19 patients admitted to the ICU undergo a thromboelastography (TEG) to test for the risk of forming blood clots. This recommendation comes after they found that more than half of the patients tested under these same conditions developed clinically significant blood clots that went undetected using routine screenings.

The findings appear in in the latest edition of JAMA Network Open.

"As the surgical critical care team at Baylor St. Luke's Medical Center was discussing their work in the ICU a few weeks ago, I was amazed to hear them express that one of their greatest challenges was that the central intravenous and arterial lines and the dialysis catheters kept unexpectedly clotting in COVID-19 patients in the ICU," said Dr. Todd Rosengart, chair and professor of the Michael E. DeBakey Department of Surgery at Baylor and senior author of the paper. "I'd never seen or heard anything like this in my 30 years as a surgeon, even in our sickest patients."

This prompted Rosengart and colleagues to look at what types of tests could be performed to identify these otherwise undetected blood clots.

Researchers observed 21 patients with confirmed COVID-19 infection admitted to the Baylor St. Luke's Medical Center ICU between March 15 and April 9. They found that the standard clotting profile or screening of the patients was fairly normal. They were then moved to the next level of more specific clotting tests, which included analyzing a patient's fibrinogen and D dimer levels. Fibrinogen is the protein that makes up the clot and D dimer levels are used to indicate the rate at which a patient's clots are being broken down, which would usually suggest that the body is "chewing up" all of the clotting factors.

For the COVID-19 patients in the ICU, researchers found that the levels of fibrinogen were more than three times the normal range, indicating that the body was churning out this protein. Looking at these two results together, there was no clear indication that these patients were at increased risk for forming blood clots.

At this point, the researchers looked to a third tier of tests that is not a regularly used process in most ICU patients, the thromboelastography test. This test looks at how quickly a clot forms, its strength and stability. It is used mostly for open heart surgery patients who often have abnormal clot function and also is commonly used for trauma patients.

This test showed the researchers two things: the patients who they found were clotting their central intravenous and arterial lines and dialysis catheters had abnormally high clotting function compared to the patients who did not have clotting issues, and the clot breakdown function was significantly higher in the patients who were clotting less than others.

Among the 21 patients studied, 13 of them, or 62%, developed 46 blood clots that could only be detected through the TEG test.

For patients who are at a higher risk of blood clots as indicated by the TEG test, the researchers recommend administering additional blood thinners.

"The TEG test should be performed on all COVID-19 ICU patients immediately to find those who are at a higher risk of clotting," Rosengart said. "At the point where physicians discover that their central line and catheter is clotting, the horse is out of the barn."

The researchers are now looking at whether these undetected blood clots could be related to the unexplained deaths they are seeing in COVID-19 patients.
-end-
Others who participated in the research include Dr. Jared Robert Mortus, Dr. Stephen E. Manek, Dr. Lisa Suzanne Brubaker, Dr. Michele Loor, Dr. Miguel Angel Cruz and Dr. Barbara W. Trautner, all with Baylor College of Medicine.

Brubaker is supported by the NIH/NHLBI T32 HL139425; Trautner is supported in part by the Center for Innovations in Quality, Effectiveness and Safety (CIN 13-413) at the Michael E. DeBakey VA Medical Center; and Cruz is supported in part by the Center for Translational Research on Inflammatory Disease (CTRID), Michael E. DeBakey VA Medical Center.

Baylor College of Medicine

Related Blood Clots Articles from Brightsurf:

New cause of COVID-19 blood clots identified
A new study reveals that COVID-19 triggers production of antibodies circulating through the blood, causing clots in people hospitalized with the disease.

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

COVID-19 may cause deadly blood clots
COVID-19 may increase the risk of blot cots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.

New evidence for how blood clots may form in very ill COVID-19 patients
Neutrophil Extracellular Traps (NETs) have been implicated in causing excessive clotting in cancer patients.

Researchers find new way to detect blood clots
Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.

High rate of blood clots in COVID-19
COVID-19 is associated with a high incidence of venous thromboembolism, blood clots in the venous circulation, according to a study conducted by researchers at Brighton and Sussex Medical School (BSMS), UK.

New tool helps distinguish the cause of blood clots
A new tool using cutting-edge technology is able to distinguish different types of blood clots based on what caused them, according to a study published today in eLife.

Hookah smoke may be associated with increased risk of blood clots
In a new study conducted in mice, researchers found that tobacco smoke from a hookah caused blood to function abnormally and be more likely to clot and quickly form blood clots.

Reducing the risk of blood clots in artificial heart valves
People with mechanical heart valves need blood thinners on a daily basis, because they have a higher risk of blood clots and stroke.

New study provides insight into the mechanisms of blood clots in cancer patients
Researchers have identified a potential new signaling pathway that may help further the understanding of blood clot formation in cancer patients and ultimately help prevent this complication from occurring.

Read More: Blood Clots News and Blood Clots Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.